SBF2-AS1 is upregulated in esophageal squamous cell carcinoma (ESCC), cervical cancer (CC), hepatocellular carcinoma (HCC), and osteosarcoma (OS) to promote the development of cancer, and its expression is associated with poor prognosis [7–10]. This evidence concerns the gene SBF2 and esophageal squamous cell carcinoma.